Unilever’s Baby Dove wash and lotion has fallen foul of guidelines set by the UK’s ad watchdog, which ruled the product does not benefit the skin microbiome, unless proof
can be presented.
In the ruling dated 13 Jan 2021, The Advertising Standards Authority (ASA) stated the social media ad, used a series of statements suggesting the product could “nourish” a baby’s skin microbiome.
Responding to accusations the ad was misleading and could not be substantiated, Unilever said the claims did not state or imply the products could be used to make a medical diagnosis or treat or prevent disease, including injury, ailment or adverse condition.
By Will Chu – 12 Jan 2021
Kristel Adriaenssens Milet 1 April 2025 Social intelligence company Dynvibe, which specialises in behavioural marketing…
26 March 2025 The 35th IFSCC Congress will take place in Cannes from September 15…
This AI-powered skin diagnostic device uses bio-optical technology alongside AI algorithms to analyze the skin’s…